Candela KK President Toshio Mori Shares Stories of Growth and Success with Vbeam® in Japan

Candela KK, a subsidiary of Candela with four locations in Japan, has been experiencing great success with the Vbeam. Since the marketing campaign of the system began in July 2010, sales of the laser treatment technology have been very successful, resulting in the sale of more units in five months’ time than the original model sold over a span of two years. Mr. Toshio Mori, president of Candela KK, gave three reasons that have contributed to Vbeam’s success. “First, the Dynamic Cooling Device™ (DCD™) that is integrated into the Vbeam works better and is safer than the old PDL technology for treating vascular lesions. Secondly, Vbeam can offer more clinical applications, as it is not limited to vascular lesions but can also be used for skin rejuvenation, inflammatory acne, warts, and solar lentigines. Lastly, Vbeam laser treatment for port wine stains, hemangiomas, and telangiectasia can now be reimbursed by Japan’s National Healthcare insurance.” Mr. Mori noted that no other long-pulsed dye laser has this distinction.

When asked what the Japanese market values in an aesthetics technology provider and how Candela systems stand apart from the competition, Mr. Mori believes that understanding how to make optimal use of the product goes a long way after the sale towards customer satisfaction. Top-selling models like the Vbeam or the GentleLASE^® seem to be preferred more by physicians because there are more resources available after the sale. “Providing an aesthetic technology won’t help physicians build their patient base or generate more revenue unless they clearly understand how to offer the best treatment using that technology,” said Mr. Mori. “Having the opportunity to exchange ideas at workshops or seminars is extremely important, because those ideas turn into valuable feedback to current and future customers.”

Mr. Mori also noted success in Japan with other Syneron-Candela products, namely the CO₂RE™ system which is currently generating the most sales leads.

According to Mr. Mori, having the support of Candela’s clinical team in the United States as well as its tech support team is instrumental to Candela KK’s success. “Physicians are very confident with the Candela brand because we continually do the right thing before, during, and after the sale.”